Skip to main navigation Skip to search Skip to main content

STRIDE: Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus

Grants and Contracts Details

StatusActive
Effective start/end date3/20/25 → 3/20/27

Funding

  • CereVasc Incorporated: $50,270.00